|
|
|
|
 |
 |
Richard K. Parrish II, MD
Symposium Moderator
Professor
Department of Ophthalmology
Bascom Palmer Eye Institute
Associate Dean for Graduate Medical Education
University of Miami School of Medicine
Miami, Florida
|
|
Richard K. Parrish II, MD, graduated from Indiana University
with a Bachelor of Arts in Biological Sciences and then received
his medical degree from Indiana University School of Medicine
in 1976. He completed an internship in medicine at the University
of Alabama, a residency and chief residency at Wills Eye Hospital
in Philadelphia, Pennsylvania, and both clinical and research
fellowships in glaucoma at the Bascom Palmer Eye Institute/Anne
Bates Leach Eye Hospital at the University of Miami School
of Medicine in Miami, Florida. He is currently the Associate
Dean for Graduate Medical Education and a Professor at the
University of Miami School of Medicine.
Dr. Parrish is an Editorial Board Member and Associate Editor
for the American Journal of Ophthalmology, on the Editorial
Board for Ophthalmic Surgery and Lasers, Ophthalmology
Times, and Contemporary Ophthalmology, and a Contributing
Editor to Ophthalmic Practice. He is a member of the
American Academy of Ophthalmology and the Society for Clinical
Trials, and has received both the Honor Award and Senior Honor
Award from the American Academy of Ophthalmology.
Numerous universities across the United States and around
the world have invited Dr. Parrish to speak, and he has also
presented at meetings for the American Academy of Ophthalmology,
Bascom Palmer Eye Institute, American Glaucoma Society, and
the Pan-American Congress of Ophthalmology. He has written
chapters in several books, contributed articles to such journals
as Ophthalmology, Archives of Ophthalmology,
and the American Journal of Ophthalmology, and has
written numerous other professional publications.
DISCLOSURE
Dr. Parrish has disclosed the following relationships
active within the previous 12 months:
Grant/Research Support: Pharmacia Corporation
Consultant: Cambridge Antibody Technology Group,
Glaukos Corporation, Pharmacia Corporation
Speakers' Bureau: Alcon Laboratories, Inc.
|
 |
|
Michael A. Kass, MD
Project Chairman of the OHTS
Professor and Chair
Ophthalmology and Visual Sciences
Washington University School of Medicine, St. Louis
St. Louis, Missouri |
|
Michael A. Kass, MD, received a bachelor’s degree and
a medical degree from Northwestern University Medical School
in Chicago, Illinois. He completed a residency in Ophthalmology
and was a clinical fellow in glaucoma at Washington University
School of Medicine in St. Louis, Missouri. Dr. Kass is currently
Chairman of the Department of Ophthalmology and Visual Sciences
at Washington University School of Medicine in St. Louis.
Dr. Kass is the Chairman of the Ocular Hypertension Treatment
Study, funded by the National Institutes of Health, and has
authored several articles about the study. He has also written
more than 100 articles on other ophthalmology topics, as well
as many abstracts and chapters in books.
As a fellow of the American Academy of Ophthalmology, Dr.
Kass has received both a recognition award and a Senior Honor
Award from that organization. He is also a Diplomate of the
American Board of Ophthalmology, and a member of both the
American Glaucoma Society and the American Medical Association.
Dr. Kass is a scientific reviewer for several journals, including
Annals of Internal Medicine, Current Eye Research,
the Journal of the American Medical Association, and
the Journal of Glaucoma. He is also a Director of the
Heed Ophthalmic Foundation.
DISCLOSURE
Dr. Kass has disclosed the following relationships active
within the previous 12 months:
Grant/Research Support: Merck & Co., Inc.
Consultant: Merck & Co., Inc., Pharmacia Corporation
|
 |
|
Donald L. Budenz, MD
Associate Professor
Bascom Palmer Eye Institute
University of Miami School of Medicine
Miami, Florida |
|
Donald L. Budenz, MD, graduated magna cum laude from the
University of Pennsylvania with a bachelor’s degree in
Psychology and received his medical degree from Harvard Medical
School in 1987. He completed an internship in Internal Medicine
at Bryn Mawr Hospital in Pennsylvania and an Ophthalmology
residency at the University of Pennsylvania. He was Assistant
Chief of Service and a member of the glaucoma service at the
University of Pennsylvania for 2 years. Dr. Budenz also completed
a Heed Foundation Fellowship in Glaucoma at the University
of Miami School of Medicine, where he subsequently became
a faculty member. He became associate professor of Ophthalmology
at that institution in 1999.
Dr. Budenz is an editorial reviewer for several medical journals,
including Ophthalmology, Archives of Ophthalmology,
American Journal of Ophthalmology, Investigative
Ophthalmology and Visual Science, Journal of Glaucoma,
Retina, Eye, and Ophthalmic Surgery and Laser
Therapy. He has been the principal investigator in a number
of clinical trials on ocular hypertension that have been funded
by the National Eye Institute and National Institutes of Health.
He also received a research grant from the University of Pennsylvania
to investigate in vivo gene transfer into the murine trabecular
meshwork and corneal endothelial cells. Concurrent with his
research, Dr. Budenz has been published widely in the field
of glaucoma; he has authored a textbook, Atlas of Visual
Fields, contributed chapters to several other books, and
written or coauthored more than 50 peer-reviewed journal articles.
Dr. Budenz is the recipient of a Golden Apple Award for Best
Resident Teacher (University of Pennsylvania School of Medicine)
and has been a guest lecturer at numerous universities, hospitals,
and medical societies in North America, Europe, and South
America. He is a member of the American Academy of Ophthalmology,
the Association for Research in Ophthalmology and Visual Sciences,
the Society of Heed Fellows, and the Florida Society of Ophthalmology.
He is currently a graduate student in Epidemiology at the
Johns Hopkins School of Public Health.
DISCLOSURE
Dr. Budenz has disclosed the following relationships active
within the previous 12 months:
Grant/Research Support: Pharmacia Corporation
Consultant: Pharmacia Corporation
Speakers’ Bureau: Pharmacia Corporation
|
 |
|
M. Roy Wilson, MD
Vice President for Health Sciences
and Dean, School of Medicine
Creighton University
Omaha, Nebraska |
|
M. Roy Wilson, MD, MS, graduated magna cum laude from Allegheny
College in Meadville, Pennsylvania in 1976 and received his
medical degree from Harvard Medical School in 1980. He then
completed an internship in Internal Medicine at Harlem Hospital
Center, as well as a residency in Ophthalmology and a fellowship
in Glaucoma at the Massachusetts Eye & Ear Infirmary of
Harvard Medical School. Dr. Wilson later completed a Master
of Science in Epidemiology at UCLA in 1990. He has served
as a professor at Charles R. Drew University of Medicine and
Science and at UCLA. Currently, Dr. Wilson is the Dean of
the School of Medicine and Vice President for Health Sciences
at Creighton University in Omaha, Nebraska. He also works
at Saint Joseph Hospital in Omaha, Nebraska.
Dr. Wilson has received numerous awards, including an Honor
Award from the American Academy of Ophthalmology, and has
been listed in Best Doctors in America since 1996. He is a
member of the Association for Research in Vision and Ophthalmology,
the American Academy of Ophthalmology, the American Glaucoma
Society, and the American Ophthalmological Society. He serves
on the Glaucoma Advisory Committee for Prevent Blindness America.
Dr. Wilson serves as a reviewer for such publications as
the Journal of Glaucoma, American Journal of Ophthalmology,
Ophthalmology, Journal of the American Medical Association,
and Archives of Ophthalmology. He is on the Editorial
Advisory Board for Focus on Glaucoma and the Editorial
Board for Archives of Ophthalmology. Dr. Wilson has
received grants for numerous clinical trials; has given presentations
for the National Medical Association, the American Academy
of Ophthalmology, and the American Glaucoma Society; and has
published numerous articles on glaucoma and other topics.
DISCLOSURE
Dr. Wilson has disclosed the following relationships active
within the previous 12 months:
Consultant: Pharmacia Corporation
|
 |
|
Paul Palmberg, MD, PhD
Professor
Bascom Palmer Eye Institute
University of Miami School of Medicine
Miami, Florida |
|
Paul Palmberg, MD, PhD, is Professor of Ophthalmology at
the Bascom Palmer Eye Institute, University of Miami School
of Medicine, in Miami, Florida. He received both his medical
degree and his PhD in biochemistry from Northwestern University
in Chicago, Illinois, and completed his residency, chief residency,
clinical and research glaucoma fellowships at Washington University
in St. Louis, Missouri.
Dr. Palmberg’s work in the field of glaucoma research
has primarily concerned the relationship between intraocular
pressure and visual field progression, useful in choosing
“target pressures,” a term he introduced in helping
to write the American Academy of Ophthalmology’s first
preferred practice pattern for Primary Open-Angle Glaucoma.
He has been studying the use of antimetabolites in filtering
surgery since 1982, and has developed techniques to deal with
such side effects as hypotony maculopathy and painful or leaking
blebs. He is a co-recipient of the International Glaucoma
Review Award for the most significant glaucoma research in
the year 2000 for his role in the AGIS report on the relationship
between IOP and visual field loss.
Outside of clinical glaucoma work, he performed the natural
history study of diabetic retinopathy that was the basis for
the Diabetes Control and Complications Trial, introduced HEPES
buffer and a color indicator in corneal preservation media
(Modified MK media), and studied trabecular cell biology.
Dr. Palmberg has authored or coauthored more than 80 journal
articles and book chapters, lectured in 42 countries, and
trained 48 clinical fellows and 92 foreign observer fellows.
DISCLOSURE
Dr. Palmberg has disclosed the following relationships active
within the previous 12 months:
Consultant: Merck & Co., Inc., Pharmacia Corporation
Speakers’ Bureau: Alcon Laboratories, Inc.,
Allergan Inc., Merck & Co., Inc., Pharmacia Corporation
©2003-2005 ImproMED.
Privacy Policy/Legal
Statement/Disclaimer
|
|
|
|
